VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

ISA 2022 | Findings of the ISA survey on COVID-19 infection in patients with systemic amyloidosis

Paolo Milani, MD, PhD, Amyloidosis Research and Treatment Center, Pavia, Italy, comments on the key results of the ISA survey on COVID-19 infection in patients with AL and ATTR amyloidosis. Overall, the survey found that the mortality rate in these cohorts is similar to that of patients with hematological malignancies. This interview took place at the 2022 International Symposium on Amyloidosis (ISA) held in Heidelberg, Germany.

Disclosures

Janssen-Cilag

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter